GlassScriptPhysician profile
Atul Prakash
NPI 1427085109
$10,762.43
in general payments reported to CMS, 2019-2025
27 companies · $1,754 in 2025
The $1,754 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,193 · 2020: $475 · 2021: $897 · 2022: $361 · 2023: $4,513 · 2024: $570 · 2025: $1,754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Food and Beverage: $1,938 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $800 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Food and Beverage | $1,938.47 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $800.00 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $5,287.51 | 2019-2025 | Solia, Edora 8 Dr-T, Biomonitor |
| Boston Scientific Corporation | $2,409.66 | 2019-2025 | Watchman Flx, Watchman Access System, Versacross Access Solution |
| Amgen INC. | $370.12 | 2020-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $314.35 | 2019-2023 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $307.61 | 2019-2024 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $258.62 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $209.54 | 2021-2025 | Verquvo |
| Biosense Webster, INC. | $207.43 | 2020-2022 | |
| Abiomed | $163.50 | 2023-2025 | Impella |
| Medtronic, INC. | $153.02 | 2021-2025 | Cobalt Dr Mri Surescan, N/A |
| Medtronic Vascular, INC. | $148.90 | 2019 | |
| Abbott Laboratories | $148.52 | 2019-2024 | Assurity |
| Astrazeneca Pharmaceuticals LP | $127.17 | 2021-2024 | Farxiga |
| Edwards Lifesciences Corporation | $124.10 | 2021 | |
| Bardy Diagnostics, INC. | $106.27 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $97.61 | 2021-2024 | Mynx Control, Mynx Venous Vcd |
| Pfizer INC. | $90.28 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.08 | 2025 | |
| Catheter Precision INC. | $29.41 | 2025 | |
| Cardinal Health 200 LLC | $28.99 | 2020 | |
| Janssen Pharmaceuticals, INC | $28.75 | 2019 | |
| Sun Pharmaceutical Industries INC. | $28.17 | 2021 | |
| Bridgebio Pharma, INC. | $17.76 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.75 | 2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $14.93 | 2021 | |
| Heartflow, INC. | $13.11 | 2024 | |
| Amarin Pharma, INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atul Prakash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.